Study of the Safety of HPN-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)
This study has been completed.
Sponsor:
Hyperion Therapeutics, Inc.
Information provided by:
Hyperion Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT00947297
First received: July 24, 2009
Last updated: August 19, 2010
Last verified: August 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |